Full Text View
Tabular View
No Study Results Posted
Related Studies
Randomized Trial Comparing Endoscopy and Surgery for Pancreatic Cyst-Gastrostomy
This study is currently recruiting participants.
Study NCT00826501   Information provided by University of Alabama at Birmingham
First Received: January 20, 2009   No Changes Posted
This Tabular View shows the required WHO registration data elements as marked by

January 20, 2009
January 20, 2009
February 2008
Treatment success rate defined as ability to successfully drain the pseudocyst and patient being relieved of symptoms [ Time Frame: 18 months ] [ Designated as safety issue: Yes ]
Same as current
No Changes Posted
Quality of Life following treatment which will be assessed on a 3-month basis for 18-months using the SF-36 questionnaire [ Time Frame: 18 months ] [ Designated as safety issue: No ]
Same as current
 
Randomized Trial Comparing Endoscopy and Surgery for Pancreatic Cyst-Gastrostomy
Randomized Trial Comparing Endoscopy and Surgery for Pancreatic Cyst-Gastrostomy

Patients with pancreatitis can develop inflammatory fluid collection around the pancreas called pseudocysts. Pseudocysts may cause abdominal pain when they are more than 6cm in size. These pseudocysts can be treated (drained) by surgery or by endoscopy. Both treatment options are the current standard-of-care at all institutions around the World. The aim of this study is to identify the better of the two techniques, surgery versus endoscopy, for treatment of patients with pancreatic pseudocysts. This will be done by comparing a) the treatment success rates b) quality of life of patients following treatment and c) cost associated with treatment, between both treatment modalities.

 
 
Interventional
Treatment, Randomized, Open Label, Uncontrolled, Parallel Assignment, Safety/Efficacy Study
Pancreatic Pseudocysts
  • Procedure: Endoscopic cyst-gastrostomy
  • Procedure: Surgical cyst-gastrostomy
  • Active Comparator: Endoscopic cyst-gastrostomy
  • Active Comparator: Surgical cyst-gastrostomy
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
30
November 2009
June 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • age > 19yrs
  • able to provide informed consent
  • pancreatic pseudocyst by CT

Exclusion Criteria:

  • age < 19yrs
  • unable to consent
  • pancreatic abscess or necrosis
Both
19 Years to 85 Years
No
 
United States
 
 
NCT00826501
Shyam Varadarajulu, University of Alabama at Birmingham
 
University of Alabama at Birmingham
 
 
University of Alabama at Birmingham
January 2009

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.